(Q50573887)

15 March 2018

title

Synthesis and biological evaluation of nucleoside analogues having 6-chloropurine as anti-SARS-CoV agents. (English)

1 reference

15 March 2018

0 references

1 reference

2

1 reference

15 March 2018

Ichiro Kurane

6

object named as

Ichiro Kurane

1 reference

15 March 2018

3

Shigeru Morikawa

1 reference

15 March 2018

Shuetsu Fukushi

4

object named as

Shuetsu Fukushi

1 reference

15 March 2018

Tetsuya Mizutani

5

object named as

Tetsuya Mizutani

1 reference

15 March 2018

author name string

Masahiro Ikejiri

1

1 reference

15 March 2018

Tokumi Maruyama

7

1 reference

15 March 2018

language of work or name

English

0 references

publication date

13 February 2007

1 reference

15 March 2018

number of pages

4

1 reference

Bioorganic & Medicinal Chemistry Letters

inferred from page(s)

published in

1 reference

15 March 2018

volume

17

1 reference

15 March 2018

issue

9

1 reference

15 March 2018

page(s)

2470-2473

1 reference

15 March 2018

Severe acute respiratory syndrome (SARS) coronavirus: application of monoclonal antibodies and development of an effective vaccine

cites work

1 reference

12 December 2020

Structural insights into SARS coronavirus proteins

1 reference

12 December 2020

Synthesis and antiviral activity of carbocyclic oxetanocin analogues (C-OXT-A, C-OXT-G) and related compounds. II.

1 reference

12 December 2020

Lobucavir is phosphorylated in human cytomegalovirus-infected and -uninfected cells and inhibits the viral DNA polymerase

1 reference

12 December 2020

Potential antivirals and antiviral strategies against SARS coronavirus infections

1 reference

12 December 2020

Synthesis and antiviral activity of 6-chloropurine arabinoside and its 2'-deoxy-2'-fluoro derivative

1 reference

12 December 2020

Design and synthesis of dipeptidyl glutaminyl fluoromethyl ketones as potent severe acute respiratory syndrome coronovirus (SARS-CoV) inhibitors

1 reference

12 December 2020

Mechanism-based enzyme inactivators

1 reference

12 December 2020

Synthesis of 9-(2,3-dideoxy-2-fluoro-beta-D-threo-pentofuranosyl)adenine (FddA) via a purine 3'-deoxynucleoside

1 reference

12 December 2020

Synthesis and antiviral activity of 9-[4-hydroxy-3-(hydroxymethyl)but-1-yl]purines

1 reference

12 December 2020

Synthesis of cyclopentenyl carbocyclic nucleosides as potential antiviral agents against orthopoxviruses and SARS.

1 reference

12 December 2020

Inhibitory effect of mizoribine and ribavirin on the replication of severe acute respiratory syndrome (SARS)-associated coronavirus

1 reference

12 December 2020

Inhibition of RNA polymerase and formyltetrahydrofolate synthetase activity by 6-chloro-8-aza-9-cyclopentylpurine. Structure-activity relationships

1 reference

12 December 2020

Synthesis, biological activity and molecular modeling of 6-benzylthioinosine analogues as subversive substrates of Toxoplasma gondii adenosine kinase

1 reference

12 December 2020

Synthesis, crystal structure, structure-activity relationships, and antiviral activity of a potent SARS coronavirus 3CL protease inhibitor

1 reference

12 December 2020

Approaches to isozyme-specific inhibitors. 17. Attachment of a selectivity-inducing substituent to a multisubstrate adduct. Implications for facilitated design of potent, isozyme-selective inhibitors

1 reference

12 December 2020

Ribose-Modified Adenosine Analogs as Potential Partial Agonists for the Adenosine Receptor

1 reference

12 December 2020

Irreversible inhibitors of serine, cysteine, and threonine proteases

1 reference

12 December 2020

Hosting the severe acute respiratory syndrome coronavirus: specific cell factors required for infection

1 reference

12 December 2020

Synthesis and biological evaluation of phosphonopyrimidine and phosphonopurine ribonucleosides

1 reference

12 December 2020

Orthogonal activation of the reengineered A3 adenosine receptor (neoceptor) using tailored nucleoside agonists

1 reference

12 December 2020

Severe acute respiratory syndrome epidemic in Taiwan, 2003.

1 reference

12 December 2020

Antiviral activity of glycyrrhizic acid derivatives against SARS-coronavirus

1 reference

12 December 2020

10.1016/J.BMCL.2007.02.026

Identifiers

DOI

1 reference

15 March 2018

PMC publication ID

7126875

0 references

1 reference

15 March 2018